However, when compared with the control group, p-AMPK, PGC-1α, and SIRT3 expression levels were significantly decreased in the CHF model group (P < 0.05 or P < 0.01; Figures 12A–H). This evidence concerns the gene PPARGC1A and congestive heart failure.